Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

The impact of SHS exposure on health status and exacerbations among patients with COPD

Authors Mark D Eisner, Carlos Iribarren, Edward H Yelin, Stephen Sidney, et al.

Published Date May 2009 Volume 2009:4 Pages 169—176

DOI http://dx.doi.org/10.2147/COPD.S4681

Published 6 May 2009

Mark D Eisner1,3, Carlos Iribarren3, Edward H Yelin2, Stephen Sidney3, Patricia P Katz2, Gabriela Sanchez3, Paul D Blanc1

1Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine; 2Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco, CA, USA; 3Division of Research, Kaiser Permanente, Oakland, CA, USA

Abstract: Secondhand smoke (SHS) is a major contributor to indoor air pollution. Because it contains respiratory irritants, it may adversely influence the clinical course of persons with chronic obstructive pulmonary disease (COPD). We used data from nonsmoking members of the FLOW cohort of COPD (n = 809) to elucidate the impact of SHS exposure on health status and exacerbations (requiring emergency department visits or hospitalization). SHS exposure was measured by a validated survey instrument (hours of exposure during the past week). Physical health status was measured by the SF-12 Physical Component Summary Score and disease-specific health-related quality of life (HRQL) by the Airways Questionnaire 20-R. Health care utilization for COPD was determined from Kaiser Permanente Northern California computerized databases. Compared to no SHS exposure, higher level SHS exposure was associated with poorer physical health status (mean score decrement −1.78 points; 95% confidence interval [CI] −3.48 to −0.074 points) after controlling for potential confounders. Higher level SHS exposure was also related to poorer disease-specific HRQL (mean score increment 0.63; 95% CI 0.016 to 1.25) and less distance walked during the Six-Minute Walk test (mean decrement −50 feet; 95% CI −102 to 1.9). Both lower level and higher level SHS exposure was related to increased risk of emergency department (ED) visits (hazard ratio [HR] 1.40; 95% CI 0.96 to 2.05 and HR 1.41; 95% CI 0.94 to 2.13). Lower level and higher level SHS exposure were associated with a greater risk of hospital-based care for COPD, which was a composite endpoint of either ED visits or hospitalizations for COPD (HR 1.52; 95% CI 1.06 to 2.18 and HR 1.40; 95% CI 0.94 to 2.10, respectively). In conclusion, SHS was associated with poorer health status and a greater risk of COPD exacerbation. COPD patients may comprise a vulnerable population for the health effects of SHS.

Keywords: chronic obstructive pulmonary disease, chronic bronchitis, pulmonary emphysema, tobacco smoke pollution

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

Neeta Thakur, Paul D Blanc, Laura J Julian, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:263-269

Published Date: 10 August 2010

Readers of this article also read:

Specifically targeted delivery of protein to phagocytic macrophages

Yu M, Chen Z, Guo W, Wang J, Feng Y, Kong X, Hong Z

International Journal of Nanomedicine 2015, 10:1743-1757

Published Date: 4 March 2015

Surface-enhanced Raman spectroscopy of saliva proteins for the noninvasive differentiation of benign and malignant breast tumors

Feng S, Huang S, Lin D, Chen G, Xu Y, Li Y, Huang Z, Pan J, Chen R, Zeng H

International Journal of Nanomedicine 2015, 10:537-547

Published Date: 12 January 2015

Inhibited biofilm formation and improved antibacterial activity of a novel nanoemulsion against cariogenic Streptococcus mutans in vitro and in vivo

Li YF, Sun HW, Gao R, Liu KY, Zhang HQ, Fu QH, Qing SL, Guo G, Zou QM

International Journal of Nanomedicine 2015, 10:447-462

Published Date: 9 January 2015

Promoting physical activity for elders with compromised function: the Lifestyle Interventions and Independence for Elders (LIFE) Study physical activity intervention

Rejeski WJ, Axtell R, Fielding R, Katula J, King AC, Manini TM, Marsh AP, Pahor M, Rego A, Tudor-Locke C, Newman M, Walkup MP, Miller ME, LIFE Study Investigator Group

Clinical Interventions in Aging 2013, 8:1119-1131

Published Date: 12 September 2013

The effectiveness of acupuncture on the sleep quality of elderly with dementia: a within-subjects trial

Kwok T, Leung PC, Wing YK, Ip I, Wong B, Ho DWH, Wong WM, Ho F

Clinical Interventions in Aging 2013, 8:923-929

Published Date: 31 July 2013

In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles

Shi L, Wang XL, Zhao F, Luan HS, Tu QF, Huang Z, Wang H, Wang HW

International Journal of Nanomedicine 2013, 8:2669-2676

Published Date: 24 July 2013

Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex

Zhang J, Peng Q, Shi S, Zhang Q, Sun X, Gong T, Zhang Z

International Journal of Nanomedicine 2011, 6:3405-3414

Published Date: 19 December 2011

Direct costs of chronic obstructive pulmonary disease among managed care patients

Anand A Dalal, Laura Christensen, Fang Liu, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:341-349

Published Date: 30 September 2010